118 related articles for article (PubMed ID: 32519463)
1. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
Front Immunol; 2019; 10():3137. PubMed ID: 32038644
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR.
Spinelli C; Adnani L; Meehan B; Montermini L; Huang S; Kim M; Nishimura T; Croul SE; Nakano I; Riazalhosseini Y; Rak J
Nat Commun; 2024 Apr; 15(1):2865. PubMed ID: 38570528
[TBL] [Abstract][Full Text] [Related]
5. Changes Induced by P2X7 Receptor Stimulation of Human Glioblastoma Stem Cells in the Proteome of Extracellular Vesicles Isolated from Their Secretome.
Di Giuseppe F; Ricci-Vitiani L; Pallini R; Di Pietro R; Di Iorio P; Ascani G; Ciccarelli R; Angelucci S
Cells; 2024 Mar; 13(7):. PubMed ID: 38607010
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex.
Vadla R; Miki S; Taylor B; Kawauchi D; Jones BM; Nathwani N; Pham P; Tsang J; Nathanson DA; Furnari FB
bioRxiv; 2023 Jul; ():. PubMed ID: 37461511
[TBL] [Abstract][Full Text] [Related]
7. Mechanosensitive expression of the mesenchymal subtype marker connective tissue growth factor in glioblastoma.
Grundy TJ; Orcheston-Findlay L; de Silva E; Jegathees T; Prior V; Sarker FA; O'Neill GM
Sci Rep; 2022 Sep; 12(1):14982. PubMed ID: 36056123
[TBL] [Abstract][Full Text] [Related]
8. Hsp70 and Calcitonin Receptor Protein in Extracellular Vesicles from Glioblastoma Multiforme: Biomarkers with Putative Roles in Carcinogenesis and Potential for Differentiating Tumor Types.
Alberti G; Sánchez-López CM; Marcilla A; Barone R; Caruso Bavisotto C; Graziano F; Conway de Macario E; Macario AJL; Bucchieri F; Cappello F; Campanella C; Rappa F
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542389
[TBL] [Abstract][Full Text] [Related]
9. ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma.
Kim Y; You JH; Ryu Y; Park G; Lee U; Moon HE; Park HR; Song CW; Ku JL; Park SH; Paek SH
NPJ Precis Oncol; 2024 Mar; 8(1):79. PubMed ID: 38548861
[TBL] [Abstract][Full Text] [Related]
10. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
[TBL] [Abstract][Full Text] [Related]
11. D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
McKean WB; Yang J; Boucher K; Shrieve DC; Suneja G; Salzman K; Jensen R; Colman H; Cohen AL
Neurooncol Adv; 2024; 6(1):vdae063. PubMed ID: 38800698
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.
Xu C; Hou P; Li X; Xiao M; Zhang Z; Li Z; Xu J; Liu G; Tan Y; Fang C
Cancer Biol Med; 2024 May; 21(5):363-81. PubMed ID: 38712813
[TBL] [Abstract][Full Text] [Related]
13. miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition.
Jacob JR; Singh R; Okamoto M; Chakravarti A; Palanichamy K
iScience; 2024 Jan; 27(1):108650. PubMed ID: 38226170
[TBL] [Abstract][Full Text] [Related]
14. Shear stress regulation of nanoparticle uptake in vascular endothelial cells.
Zhang H; Hu Z; Wang J; Xu J; Wang X; Zang G; Qiu J; Wang G
Regen Biomater; 2023; 10():rbad047. PubMed ID: 37351014
[TBL] [Abstract][Full Text] [Related]
15. Human Blood Extracellular Vesicles Activate Transcription of NF-kB-Dependent Genes in A549 Lung Adenocarcinoma Cells.
Savinovskaya YI; Nushtaeva AA; Savelyeva AV; Morozov VV; Ryabchikova EI; Kuligina EV; Richter VA; Semenov DV
Curr Issues Mol Biol; 2022 Nov; 44(12):6028-6045. PubMed ID: 36547072
[TBL] [Abstract][Full Text] [Related]
16. PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.
Yang E; Wang L; Jin W; Liu X; Wang Q; Wu Y; Tan Y; Wang Y; Cui X; Zhao J; Tong F; Hong B; Xiao M; Liu X; Fang C; Kang C
Theranostics; 2022; 12(9):4330-4347. PubMed ID: 35673568
[No Abstract] [Full Text] [Related]
17. Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance.
Simón L; Sanhueza S; Gaete-Ramírez B; Varas-Godoy M; Quest AFG
Front Oncol; 2022; 12():897205. PubMed ID: 35646668
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma.
Setlai BP; Hull R; Reis RM; Agbor C; Ambele MA; Mulaudzi TV; Dlamini Z
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205289
[TBL] [Abstract][Full Text] [Related]
19. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles.
Tominaga N
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944923
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]